Haven't used AliveGen USA yet?
Ask Trustburn

What reviewers say about AliveGen USA

Based on 12 reviews, listing data and website checks · updated 3 days ago

Across the cross-section of reviews on file, customers consistently describe AliveGen USA products as excellent or high quality and the alivegen.com website as easy to navigate and user-friendly, with several reviewers stating they would recommend the company or purchase again.
What is AliveGen USA?

AliveGen USA is a privately held clinical-stage biopharmaceutical company located in Thousand Oaks, California, focused on the discovery and development of novel biotherapeutics to combat muscle and bone loss and loss of functional capacity in conditions like neuromuscular diseases, cancer cachexia, congestive heart failure, and geriatric sarcopenia.

What is the stated mission of AliveGen USA?

The company's stated mission is to improve patient care and quality of life by developing innovative, highly effective, and safe therapies. They aim to achieve this by creating a pipeline of novel next-generation clinical candidates using cutting-edge biotechnology.

What specific diseases does AliveGen USA target with its biotherapeutics?

According to the company's website, their area of focus includes first-in-class and best-in-class potential therapies for muscle wasting, bone loss, obesity, cardiometabolic diseases, neuromuscular disorders, chronic kidney disease, nonalcoholic fatty liver disease, fibrotic diseases, cancer, and osteosarcopenia.

How recent are the reviews and what is the rating split?

All 12 Trustburn reviews are from 2022 and 2023, with the most recent dated November 18, 2023. The rating split shows 6 five-star reviews, 3 four-star reviews, and 3 three-star reviews, totaling a 4 out of 5 rating.

What themes do multiple reviewers share regarding their experience with AliveGen USA?

Reviewers consistently praise the high quality of the products, the user-friendly nature of the alivegen.com website, and the wide range of products available for purchase.

What makes AliveGen USA's approach different from competitors according to its own words?

The company describes itself as having first-in-class and best-in-class potential, distinguishing its novel biotherapeutics from other treatments that may not yet be approved for these specific chronic diseases.

How long has AliveGen USA existed and what is its team structure?

The business has been operating as a clinical-stage biopharmaceutical company since at least the time of its 2022 reviews, with a team focused on R&D and pipeline development.

What markets or countries does AliveGen USA serve?

The company serves a global market by developing therapies for chronic diseases affecting patients worldwide, including those in the US where the company is headquartered.

How can I contact AliveGen USA?

You can reach AliveGen USA by e-mail at [email protected].

What is the official website of AliveGen USA?

The official website of AliveGen USA is alivegen.com.

Based on reviews, listing data and the company's website. Verify anything important with the company directly.

Questions & Answers

No questions yet — be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="alivegen-com" data-lang="en"></div>
More widgets

About AliveGen USA

They are focused on the discovery and development of novel biotherapeutics to combat the debilitating muscle and bone loss and the loss of functional capacity, as occurs in various neuromuscular diseases, cancer cachexia, congestive heart failure, geriatric sarcopenia and frailty, as well as in other chronic diseases, for which no approved therapies are currently available.